Pfizer's Medivation Receives FDA Approval For Prostate Cancer Drug XTANDI
October 21, 2016 at 15:52 PM EDT
Investors of Pfizer Inc. (NYSE: PFE) failed to boost the sentiments after the company disclosed that its sNDA for prostate cancer drug ...